9

9amHealth

Virtual cardiometabolic care with personalized plans

Telehealth Physician

Contract
No salary listed
Mid
MD
Remote in USA
Remote
Medical, Clinical & VeterinaryPhysicians & Surgeons

About the job

Requirements
  • A medical degree (MD or DO) from an accredited institution is required.
  • Active board certification in Internal Medicine, Family Medicine, Endocrinology, Cardiology, Obesity Medicine, or a related specialty is required.
  • Experience treating cardiometabolic conditions, including type 2 diabetes, hypertension, hyperlipidemia, and obesity, is required.
  • An active medical license in the state or states where services are provided is required.
  • Strong communication skills and the ability to deliver care virtually are required.
Responsibilities
  • Conduct synchronous telehealth consultations with patients as scheduled by 9amHealth for cardiometabolic conditions, including diabetes, hypertension, obesity, and hyperlipidemia.
  • Perform medical assessments appropriate to the encounter, review patient histories, and address patient concerns within the scope of the appointment.
  • Provide medical recommendations, prescriptions, or referrals as appropriate, consistent with state medical licensure and applicable standards of care.
  • Maintain accurate documentation of patient encounters in 9amHealth’s electronic health record system, limited to information generated during the synchronous visit.
  • Complete a blend of synchronous (live) and asynchronous (non-live) patient encounters, based on patient needs and volume.
Desired Qualifications
  • Prior telemedicine experience is preferred.

About the company

9amHealth provides virtual cardiometabolic care to prevent and manage chronic conditions like diabetes, obesity, high cholesterol, and hypertension. The service uses a B2B2C model with employers, health plans, and PBMs, and also offers a direct-to-consumer subscription. Its platform delivers personalized treatment plans, access to endocrinologists and pharmacists, at-home lab testing, connected devices, and prescription delivery, guided by step-therapy from lifestyle changes and generics to GLP-1s when needed. Partnerships with Novo Nordisk, Eli Lilly, and pharmacy networks help expand affordable access to medications, while the goal is to improve outcomes by making cardiometabolic care more accessible and effective.

Company Size

51-200

Company Stage

Series B

Total Funding

$55.2M

Headquarters

Encinitas, California

Founded

2021

Get referred to 9amHealth

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 13, 2026 funding followed $50M savings across two Fortune 100 employers.
  • March 4, 2026 Withings partnership deepens remote monitoring and engagement for obesity care.
  • June 9, 2026 SmithRx included 9amHealth in employer GLP-1 partner ecosystem.

What critics are saying

  • PBMs like SmithRx commoditize 9amHealth, squeezing pricing and margin by 2027.
  • Employer GLP-1 benefit tightening hits demand if savings proof weakens after 2026.
  • If chronic-care expansion stalls, 9amHealth stays a niche virtual clinic without durable moat.

What makes 9amHealth unique

  • 9amHealth combines endocrinology, labs, devices, and meds in one cardiometabolic workflow.
  • Founders Frank Westermann and Anton Kittelberger built mySugr, acquired by Roche in 2017.
  • May 13, 2026 Series B from Define Ventures funded expansion beyond cardiometabolic care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Vision Insurance
  • Dental Insurance
  • Paid Vacation
  • Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-3%

2 year growth

0%
PR Newswire
May 13th, 2026
9amHealth raises $26M to expand AI-driven virtual care beyond cardiometabolic conditions

9amHealth, a virtual specialty care platform, has raised $26 million in Series B funding led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management and NewHealth Ventures. The company says it has generated over $50 million in projected medical and pharmacy savings across two Fortune 100 employers. Founded in 2021, 9amHealth currently focuses on cardiometabolic conditions including obesity, diabetes, hypertension and hyperlipidemia. The platform combines clinical protocols, laboratory testing, medication management and continuous care delivery. The funding will support expansion into additional high-cost chronic conditions, which the company says account for up to 70% of employer pharmacy spend. 9amHealth uses AI-enabled clinical workflows to manage complex conditions at scale, partnering with employers, health plans and pharmacy benefit managers.

FinSMEs
Feb 20th, 2024
9amHealth Raises $9.5M in Series A Extension Funding

9amHealth, a San Diego, CA-based virtual provider of cardiometabolic health care, raised $9.5M in Series A extension funding.

Trending Topics
Jul 4th, 2023
Calm/Storm Ventures: After The Foundation Comes The Storm

Calm/Storm Ventures has strong roots with business angel Hansi Hansmann, Speedinvest, and Runtastic. After the first focus on HealthTech, the next fund is about financing the best founders in Austria. 2021 was a hype year that doubled the number of unicorns worldwide to 1,058 from 586 in 2020 after massive amounts of venture capital were pumped into these tech companies. Everything was different in 2022, when mass layoffs, downrounds, and a lack of venture capital dominated the headlines. The founders and partners of the Austrian VC Calm/Storm Ventures know these two poles very well. Taken together, Lucanus Polagnoli (ex-Speedinvest), Hansi Hansmann, and Alfred Luger (ex-Runtastic) weigh in on more than 180 investments as fund managers and business angels

Trending Topics
Jun 23rd, 2023
Push Ventures: Startup-Fonds Mit Rückenwind

Nach jahrelanger Erfahrung als „einfacher“ Investor ­startete PUSH Ventures im ­vergangenen Jahr einen ersten großen und ­registrierten Investment-Fonds. Lukas Püspök und Laurenz Simbruner, die beiden Partner hinter dem VC, ­konnten den Fonds mit etwas mehr als 20 Millionen Euro auffüllen. Investiert werden soll in Health- sowie ­Climate-Startups — mit jeder Menge (familiären) Rückenwind. Der Fokus auf Klima-Startups verwundert nicht, blickt doch gerade Familie Püspök auf jahrelange Projekte in diesem Sektor zurück: Seit 1997 beschäftigt sich das Familienunternehmen mit der Stromerzeugung aus erneuerbarer Energie. Vor mehr als 20 Jahren begann die Geschichte mit der Entwicklung und Errichtung eines der ersten Windparks im Burgenland. Über zwei Jahrzehnte später setzt die nächste Generation die nächsten Schritte, gemeinsam mit Laurenz Simbruner und Investment-Manager David Aigner

Trending Topics
Jun 2nd, 2023
Calm/Storm Ventures: Nach Der Gründung Kommt Der Sturm

Calm/Storm Ventures hat mit Business Angel Hansi Hansmann, Speedinvest und Runtastic kräftige Wurzeln. Nach dem ersten Fokus auf HealthTech geht es beim nächsten Fonds darum, die besten Gründer:innen Österreichs zu finanzieren. 2021 war ein Hype-Jahr, das die Zahl der Unicorns weltweit von 586 im Jahr 2020 auf 1.058 verdoppelte, nachdem enorme Mengen an Risikokapital in diese Tech-Firmen gepumpt wurden. 2022 war alles anders, da dominierten Massenkündigungen, Downrounds und fehlendes Risikokapital die Schlagzeilen. Diese beiden Pole kennen die Gründer und Partner des österreichischen VCs Calm/Storm Ventures genau. Zusammengerechnet bringen Lucanus Polagnoli (Ex-Speedinvest), Hansi Hansmann und Alfred Luger (Ex-Runtastic) mehr als 180 Investments als Fonds-Manager bzw